The American Heart Association (AHA) has announced the expansion of its Cardiovascular-Kidney-Metabolic (CKM) Health Initiative to 15 U.S. regions, including two New York City metro areas: the Bronx and Brooklyn. This initiative targets the interconnected conditions of heart disease, kidney disease, diabetes, and obesity, collectively known as CKM syndrome, which affects a significant portion of the population. The expansion is supported by leading healthcare sponsors and aims to enroll 150 healthcare sites, impacting over a quarter-million patients by enhancing awareness, screening, and treatment.
The newly added regions, including Miami and Las Vegas, were selected based on disease prevalence and community needs. This is particularly critical for New York City, where disparities in healthcare access and outcomes are pronounced. The initiative addresses a public health emergency: only 10% of U.S. adults have excellent CKM health, according to the AHA. The Bronx and Brooklyn have high rates of obesity, diabetes, and hypertension, making this expansion vital for improving community health.
Dr. Chiadi Ndumele, chair of the initiative's advisory group, emphasized that the initiative provides an opportunity to improve CKM health through collaborative care models and evidence-based therapies. By connecting patients with community resources, the initiative aims to address health-related social needs that often hinder effective treatment. The AHA has developed a CKM Health Implementation Guide available for free to healthcare organizations.
The implications of this announcement are significant for New York City. The initiative could reduce hospitalizations and healthcare costs by preventing the progression of CKM syndrome. It also highlights the importance of integrated care models that address multiple chronic conditions simultaneously. For more information on CKM health, visit heart.org/myCKMhealth.
